Delta Burke fronts Byetta diabetes awareness tour

Share this article:
Lilly and Amylin launched “Let’s Talk,” a Byetta-branded diabetes awareness effort fronted by Delta Burke.

The campaign, launched at the New England Spring Flower Show in Boston, will stop in 10 cities through August. MS&L is handling PR on the effort.

Burke, a type 2 diabetes sufferer who uses Byetta, will put in appearances in most cities to talk about her experience with diabetes and Byetta. She will be joined by Chris Smith, who bills himself as The Diabetic Chef.  The tour also will feature Bally Total Fitness trainer Nikki Kimbrough and certified diabetes educator Virginia Valentine.

A Lilly spokesman said the tour’s content—dishing product info with a double-helping of diet and exercise tips—might be nothing new, but the choice of venues, eschewing health fairs for events with more mass-appeal, is. “We’re going to popular community events that have the highest attendance to show that type 2 diabetes is part of everyday life,” said Jamaison Schuler of Lilly PR. 

A booth will offer Byetta information to those interested, and materials will advertise the campaign’s Web site, ByettaLetsTalk.com.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...